Early access: 15,549 bills from the current Congress so far, more added daily. Data from Congress.gov, GovInfo and the House and Senate vote records, updated Oct 13, 2026.
Public Law TrackerPLTPublic Law Tracker

H.R. 10628 · Where this bill is now

In committee

Introduced in the House, sent to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned, Sep 28, 2026

119th Congress
2nd Session
H. R. 10628

A BILL

Biosimilars Access and Affordability Act

In the HouseNo vote yet

Sponsor: Rep. Nicholas A. Langworthy (R-NY-23) · Introduced Sep 28, 2026 · Health · 1 version of the text

Sources: Congress.gov actions and votes · bill text from GovInfo · latest official action Sep 28, 2026: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.”

Sections

Sections · 2